Company: CRL
Filing Date: 2025-05-23
Form Type: 8-K
Source: 0001100682-25-000023
Chunk: 0

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-05-23
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders

The Company held its Annual Meeting of Shareholders on May 20, 2025. For more information on the following proposals, see the Company’s proxy statement dated April 2, 2025. At the Company’s Annual Meeting, the following proposals were adopted by the votes specified below:

(a) The following seven (7) directors were elected to serve until our 2026 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below:

                             Number of Shares Voted For      Number of Shares Voted Against      Number of Shares Abstained      Broker Non-Votes  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  James C. Foster                            39,676,718                           1,908,059                         168,585             2,209,405  
  Nancy C. Andrews                           41,118,490                             527,489                         107,383             2,209,405  
  Reshema Kemps-Polanco                      41,361,456                             334,274                          57,632             2,209,405  
  George Llado, Sr.                          41,088,535                             556,279                         108,548             2,209,405  
  Martin W. Mackay                           41,242,976                             452,454                          57,932             2,209,405  
  Craig B. Thompson                          41,508,432                             187,344                          57,586             2,209,405  
  Virginia M. Wilson                         40,996,334                             649,369                         107,659             2,209,405  

As previously disclosed in the Company's Current Report on Form 8-K filed with the SEC on May 7, 2025, each of Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman chose not stand for re-election to the Board at the 2025 Annual Meeting, following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board). On May 20, 2025, the Board appointed Steven Barg, Mark Enyedy, Abraham Ceesay, and Paul Graves to the Board, each with a term expiring